Abacus Global Management (NYSE:ABX) has unveiled LifeARC, a proprietary AI-powered platform that generates personalized lifespan models for individuals using medical history, medications, genetics, and biometrics.
The alternative asset manager said LifeARC draws on 20 years of proprietary data to produce individualized longevity projections. “LifeARC harnesses AI to do something no competitor can match: it’s powered by 20 years of Abacus proprietary data that can’t be bought, built, or displaced,” CEO Jay Jackson told shareholders in a letter announcing the launch. “LifeARC takes an individual’s medical history, conditions, medications, genetics, and biometrics and builds a personalized lifespan model.” To deploy the technology with active clients, Abacus invested more than $50 million in Manning & Napier, an advisory firm with roughly $18 billion in assets under management and more than 3,400 clients. “You can build the best lifespan modeling platform in the world, but if it’s sitting on a server somewhere and not connected to real client portfolios, it doesn’t improve anyone’s retirement,” Jackson said. “We needed a partner who already had client relationships, client trust, and the infrastructure
Manning & Napier gave us that.” The company said it plans to pursue additional wealth management partnerships. “The technology moat is real — every LifeARC profile we build makes our model more accurate, and nobody can replicate that dataset from scratch. The timing is better than we could have planned for,” Jackson added. Abacus said LifeARC’s revenue model spans data licensing to institutions, advisory fees, and integration with insurance and annuity products, all running on the same proprietary data layer.
The company positioned the platform as central to what Jackson described as a $120 trillion intergenerational wealth transfer currently underway as Baby Boomers pass assets to their heirs